According to our results, the levels of IL-6, IL-10, IL-17A, and TNF-α are elevated in patients with active RA, with significantly higher IL-10 and IL-17A level in patients in the low and moderate disease activity, respectively, as compared to those in remission. This evidence concerns the gene IL10 and rheumatoid arthritis.